Thermosensitivity of the Reverse Transcription Process as an Inactivation Mechanism of Lentiviral Vectors

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Lentiviral vectors are an important tool for gene transfer research and gene therapy purposes. However, the low stability of these vectors affects their production, storage, and efficacy in preclinical and clinical settings. In the present work the mechanism underlying the thermosensitivity of lentiviral vectors was evaluated. For lentiviral vectors pseudotyped with amphotropic and RDpro envelopes, the capacity to perform reverse transcription was lost rapidly at 37 degrees C, in high correlation with the loss of infectivity. The vector with RDpro envelope presented a higher level of stability than that with amphotropic envelope for both the reverse transcription process and viral infectivity. Reverse transcriptase enzyme inactivation and viral template RNA degradation were not implicated in the loss of the viral capacity to perform reverse transcription. Furthermore, early entry steps in the infection process do not determine the rate of viral inactivation, as the amount of viral RNA and p24 protein entering the cells decreased slowly for both vectors. Taken together, it can be concluded that the reverse transcription process is thermolabile and thus determines the rate of lentiviral inactivation. Strategies to stabilize the reverse transcription process should be pursued to improve the applicability of lentiviral vectors in gene therapy.
Original languageUnknown
Pages (from-to)1168-1176
JournalHuman Gene Therapy
Volume20
Issue number10
DOIs
Publication statusPublished - 1 Jan 2009

Keywords

    Cite this

    @article{c90bf2526a10498aae18b2555688cfe5,
    title = "Thermosensitivity of the Reverse Transcription Process as an Inactivation Mechanism of Lentiviral Vectors",
    abstract = "Lentiviral vectors are an important tool for gene transfer research and gene therapy purposes. However, the low stability of these vectors affects their production, storage, and efficacy in preclinical and clinical settings. In the present work the mechanism underlying the thermosensitivity of lentiviral vectors was evaluated. For lentiviral vectors pseudotyped with amphotropic and RDpro envelopes, the capacity to perform reverse transcription was lost rapidly at 37 degrees C, in high correlation with the loss of infectivity. The vector with RDpro envelope presented a higher level of stability than that with amphotropic envelope for both the reverse transcription process and viral infectivity. Reverse transcriptase enzyme inactivation and viral template RNA degradation were not implicated in the loss of the viral capacity to perform reverse transcription. Furthermore, early entry steps in the infection process do not determine the rate of viral inactivation, as the amount of viral RNA and p24 protein entering the cells decreased slowly for both vectors. Taken together, it can be concluded that the reverse transcription process is thermolabile and thus determines the rate of lentiviral inactivation. Strategies to stabilize the reverse transcription process should be pursued to improve the applicability of lentiviral vectors in gene therapy.",
    keywords = "in-vivo, delivery, gene, efficient, transduction, immunodeficiency-virus, packaging, type-1, retroviral, vectors, cells, initiation, serum, particles, human",
    author = "Carrondo, {Manuel Jos{\'e} Teixeira} and Coroadinha, {Ana Sofia} and Alves, {Paula Maria}",
    year = "2009",
    month = "1",
    day = "1",
    doi = "10.1089/hum.2009.068",
    language = "Unknown",
    volume = "20",
    pages = "1168--1176",
    journal = "Human Gene Therapy",
    issn = "1043-0342",
    publisher = "Mary Ann Liebert, Inc.",
    number = "10",

    }

    TY - JOUR

    T1 - Thermosensitivity of the Reverse Transcription Process as an Inactivation Mechanism of Lentiviral Vectors

    AU - Carrondo, Manuel José Teixeira

    AU - Coroadinha, Ana Sofia

    AU - Alves, Paula Maria

    PY - 2009/1/1

    Y1 - 2009/1/1

    N2 - Lentiviral vectors are an important tool for gene transfer research and gene therapy purposes. However, the low stability of these vectors affects their production, storage, and efficacy in preclinical and clinical settings. In the present work the mechanism underlying the thermosensitivity of lentiviral vectors was evaluated. For lentiviral vectors pseudotyped with amphotropic and RDpro envelopes, the capacity to perform reverse transcription was lost rapidly at 37 degrees C, in high correlation with the loss of infectivity. The vector with RDpro envelope presented a higher level of stability than that with amphotropic envelope for both the reverse transcription process and viral infectivity. Reverse transcriptase enzyme inactivation and viral template RNA degradation were not implicated in the loss of the viral capacity to perform reverse transcription. Furthermore, early entry steps in the infection process do not determine the rate of viral inactivation, as the amount of viral RNA and p24 protein entering the cells decreased slowly for both vectors. Taken together, it can be concluded that the reverse transcription process is thermolabile and thus determines the rate of lentiviral inactivation. Strategies to stabilize the reverse transcription process should be pursued to improve the applicability of lentiviral vectors in gene therapy.

    AB - Lentiviral vectors are an important tool for gene transfer research and gene therapy purposes. However, the low stability of these vectors affects their production, storage, and efficacy in preclinical and clinical settings. In the present work the mechanism underlying the thermosensitivity of lentiviral vectors was evaluated. For lentiviral vectors pseudotyped with amphotropic and RDpro envelopes, the capacity to perform reverse transcription was lost rapidly at 37 degrees C, in high correlation with the loss of infectivity. The vector with RDpro envelope presented a higher level of stability than that with amphotropic envelope for both the reverse transcription process and viral infectivity. Reverse transcriptase enzyme inactivation and viral template RNA degradation were not implicated in the loss of the viral capacity to perform reverse transcription. Furthermore, early entry steps in the infection process do not determine the rate of viral inactivation, as the amount of viral RNA and p24 protein entering the cells decreased slowly for both vectors. Taken together, it can be concluded that the reverse transcription process is thermolabile and thus determines the rate of lentiviral inactivation. Strategies to stabilize the reverse transcription process should be pursued to improve the applicability of lentiviral vectors in gene therapy.

    KW - in-vivo

    KW - delivery

    KW - gene

    KW - efficient

    KW - transduction

    KW - immunodeficiency-virus

    KW - packaging

    KW - type-1

    KW - retroviral

    KW - vectors

    KW - cells

    KW - initiation

    KW - serum

    KW - particles

    KW - human

    U2 - 10.1089/hum.2009.068

    DO - 10.1089/hum.2009.068

    M3 - Article

    VL - 20

    SP - 1168

    EP - 1176

    JO - Human Gene Therapy

    JF - Human Gene Therapy

    SN - 1043-0342

    IS - 10

    ER -